Search Results

Alecia DeCoudreaux, the top attorney for Eli Lilly and Co.’s U.S. unit, will leave to become president of Mills College in Oakland, Calif. DeCoudreaux, 55, has worked at Indianapolis-based Lilly for 30 years after earning her law degree from Indiana University in Bloomington. As general counsel for its U.S. business, DeCoudreaux guided Lilly through all U.S. regulations, including its applications with the Food and Drug Administration to launch new drugs.

Carmel-based Zotec Partners has hired Bradley Myers as director of marketing. Prior to joining Zotec, Myers was the marketing specialist for Medical Management Professionals Inc. Myers has a marketing degree from George Mason University.

John H. Johnson, president of Indianapolis-based Eli Lilly and Co.’s oncology unit, will resign on Friday to become CEO of East Brunswick, N.J.-based biotechnology company Savient Pharmaceuticals Inc. Johnson had been CEO of New York-based ImClone Systems Inc. when Lilly acquired it in 2008.

The Indiana 21st Century Research and Technology Fund received $2.6 million from the December sale of Marcadia Biotech to Roche Diagnostics Corp. That represented a 30-percent total return on the state’s $2 million investment in the company. It is the first time the 21st Century Fund has reaped a return on one of the grants it gives to startup companies since the fund rewrote its investment rules five years ago. Before that, it simply made grants that did not have to be repaid if a company hit it big.

Hoosier Village Retirement Center in Zionsville announced plans Monday for a $32 million project that will expand its campus near Interstate 465 and Michigan Road. Hoosier Village plans a 90-unit apartment complex to replace its original residence hall, which was constructed in the 1960s, renovated in the 1990s and expanded in 2001. Hoosier Village currently has 197 independent-living units on its 150-acre campus. Plans also call for a “Memory Support Center,” licensed for residential care of residents with Alzheimer’s and other dementia-related conditions. It will have 36 private rooms and 7,500 square feet of common areas. In addition, the expansion will add a 23,700-square-foot dining center with a 250-person seating capacity, and a community center with exercise rooms, a fitness center, indoor swimming pool and locker rooms. Hoosier Village is a not-for-profit community operated by Baptist Homes of Indiana Inc. The expansion, which should begin this spring and conclude in 2013, will allow the center to add 50 full-time workers. The project is awaiting approval from the Zionsville Planning Department.

Indianapolis-based Arcadia Resources Inc. signed a three-month pilot agreement with the Cleveland Clinic under which the hospital system will use Arcadia’s DailyMed program to help chronically ill patients take their medications after being released from a hospital, thereby reducing readmissions. DailyMed dispenses a monthly cycle of a patient’s prescriptions, over-the-counter medications and vitamins, and organizes them into pre-sorted packets marked with the date and time they should be taken. Also, DailyMed pharmacists call patients, as well as their primary-care doctors and caregivers to encourage medication compliance and avoid drug interactions.

Nearly 300 physicians from Indianapolis-based Community Physicians of Indiana and Evansville-based Deaconess Clinic have joined a research network run by HealthCore Inc., a subsidiary of Indianapolis-based WellPoint Inc. The Integrated Research Network uses physicians to study drugs, devices, diagnostics and medical methods to see if real-world applications differ from results produced in clinical trials. HealthCore combines its study results with WellPoint’s records on the 33 million Americans it insures. The Deaconess Clinic has about 90 physicians in its multi-specialty physician group. Community Physicians of Indiana employs about 200 general practice physicians for the Community Health Network hospital system. The HealthCore network is currently exploring several opportunities in the areas of heart failure, pain syndromes, antibiotic resistance, Type 2 diabetes and breast cancer.